[
  {
    "ts": null,
    "headline": "3 Defensive Stocks That Can Weather Any Recession",
    "summary": "Dividend stocks are often considered safe haven or defensive stocks that can safeguard a portfolio in turbulent times.",
    "url": "https://finnhub.io/api/news?id=96a92555eb931a1fd445550ee30c63b605bf8ef5244cf12fbab51eb2ce3073b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755633898,
      "headline": "3 Defensive Stocks That Can Weather Any Recession",
      "id": 136435131,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Dividend stocks are often considered safe haven or defensive stocks that can safeguard a portfolio in turbulent times.",
      "url": "https://finnhub.io/api/news?id=96a92555eb931a1fd445550ee30c63b605bf8ef5244cf12fbab51eb2ce3073b2"
    }
  },
  {
    "ts": null,
    "headline": "MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer",
    "summary": "Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung cancer.",
    "url": "https://finnhub.io/api/news?id=a93944426207fe53890998fe6a58e292b9f48b1e48558193c5d4b7f2a2d411e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755617820,
      "headline": "MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer",
      "id": 136430258,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung cancer.",
      "url": "https://finnhub.io/api/news?id=a93944426207fe53890998fe6a58e292b9f48b1e48558193c5d4b7f2a2d411e9"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?",
    "summary": "Pfizer's oncology portfolio, boosted by Seagen and strong drug sales, fuels Q2 growth and positions the company for future cancer treatment gains.",
    "url": "https://finnhub.io/api/news?id=fca0310c9ec21b09e39ec0df49e4f42da96d9936a969295f6cab3a75caca72c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755608880,
      "headline": "Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?",
      "id": 136430192,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's oncology portfolio, boosted by Seagen and strong drug sales, fuels Q2 growth and positions the company for future cancer treatment gains.",
      "url": "https://finnhub.io/api/news?id=fca0310c9ec21b09e39ec0df49e4f42da96d9936a969295f6cab3a75caca72c2"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Canada and HPIC Mark 30 Years of Humanitarian Partnership Delivering Global Health Impact",
    "summary": "On World Humanitarian Day, Pfizer Canada is proud to mark 30 years of partnership with Health Partners International of Canada (HPIC), a collaboration that has delivered over $70 million worth of life-saving medicines to vulnerable communities across 58 countries.",
    "url": "https://finnhub.io/api/news?id=c33da0c7b44f16f27f94fda5e96d4c1677e0e8b5ae1e99ef81bd9e5528e89ae1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755604800,
      "headline": "Pfizer Canada and HPIC Mark 30 Years of Humanitarian Partnership Delivering Global Health Impact",
      "id": 136430260,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "On World Humanitarian Day, Pfizer Canada is proud to mark 30 years of partnership with Health Partners International of Canada (HPIC), a collaboration that has delivered over $70 million worth of life-saving medicines to vulnerable communities across 58 countries.",
      "url": "https://finnhub.io/api/news?id=c33da0c7b44f16f27f94fda5e96d4c1677e0e8b5ae1e99ef81bd9e5528e89ae1"
    }
  },
  {
    "ts": null,
    "headline": "Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?",
    "summary": "Pfizer's yield is high, and so too is its payout ratio.",
    "url": "https://finnhub.io/api/news?id=4845f5d3e41b2b80d5b0417187f95106df29e465f10b586b9de78378808ccde2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755593400,
      "headline": "Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?",
      "id": 136417046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's yield is high, and so too is its payout ratio.",
      "url": "https://finnhub.io/api/news?id=4845f5d3e41b2b80d5b0417187f95106df29e465f10b586b9de78378808ccde2"
    }
  }
]